ENGLAND > India’s Piramal Enterprises to acquire spasticity and pain management drugs business from Mallinckrodt for $171Mn

Pharmacovigilance-Jobs-In-Piramal-171009233200237 India based Piramal Enterprises to acquire spasticity and pain management drugs business from Mallinckrodt for Rs 1,160 crore ($171Mn). The deal consists of a clause for additional $32 million, depending on milestones met by Mallinckrodt over next three years. The portfolio of drugs acquired includes Gablofen and two pain management products, which are under development. The acquisition is expected to More …

ENGLAND > France’s IBA Molecular to acquire Nuclear Imaging business of Mallinckrodt for $690Mn

Mallinckrodt_logo France based IBA Molecular to acquire Nuclear Imaging business of Mallinckrodt for $690 million. The transaction is subject to customary closing conditions. With this deal more than 800 workforce’s as well as two manufacturing facilities will be in IBA Molecular’s hands from Mallinckrodt.   About IBA MolecularIBA Molecular is France based company that produces radioactive tracers used in molecular imaging More …

UK > India’s Piramal enterprises to acquire intrathecal therapy business of Mallinckrodt for around $203Mn

Pharmacovigilance-Jobs-In-Piramal-171009233200237 India based Piramal Enterprises to acquire intrathecal therapy business of Mallinckrodt for around $203 million. Piramal’s subsidiary Piramal Critical Care will control the intrathecal therapy business from Mallinckrodt after the acquisition. The deal is expected to close in the first quarter of 2017 when all the customary closing conditions are addressed. Intrathecal Therapy business of Mallinckrodt markets products for the More …